Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | GM MSK | October 14, 2021 | October 15, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date October 14, 2021 · Filed October 15, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 430,764 |
Reported balance
After 2021-10-14 transaction · row 1
1 source rowRow 1 · 2021-10-14 · Sale · Disposed 20,000 · Balance 430,764 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.99 to $16.46, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp.(the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.99 to $16.46, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp.(the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2021 Filed Oct 15, 2021 17:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | SaleCommon Stock | 20,000 | $16.11 | $322,200.00 |
DisclosureSEC source: 0001104659-21-126791 · tm2130131d1_4.xml · nonDerivative · entry 1 Cohen Oded · CIK 0001846154 · GM MSK 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,764 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.99 to $16.46, inclusive. The Reporting Person undertakes to provide to DarioHealth Corp.(the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 16:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantRestricted Stock Units | 73,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-033251 · tm218953d1_4.xml · nonDerivative · entry 1 Cohen Oded · CIK 0001846154 · GM MSK 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,764 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · date: The shares vest over three years as follows: 8.333% shall vest on May 1, 2021, and the remaining shares vest in 11 equal instalments every 3 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.